LLY

977.6

-2.15%↓

JNJ

242.96

-0.06%↓

ABBV

225.37

-0.98%↓

NVS

154.16

-0.82%↓

AZN

191.88

-0.58%↓

LLY

977.6

-2.15%↓

JNJ

242.96

-0.06%↓

ABBV

225.37

-0.98%↓

NVS

154.16

-0.82%↓

AZN

191.88

-0.58%↓

LLY

977.6

-2.15%↓

JNJ

242.96

-0.06%↓

ABBV

225.37

-0.98%↓

NVS

154.16

-0.82%↓

AZN

191.88

-0.58%↓

LLY

977.6

-2.15%↓

JNJ

242.96

-0.06%↓

ABBV

225.37

-0.98%↓

NVS

154.16

-0.82%↓

AZN

191.88

-0.58%↓

LLY

977.6

-2.15%↓

JNJ

242.96

-0.06%↓

ABBV

225.37

-0.98%↓

NVS

154.16

-0.82%↓

AZN

191.88

-0.58%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

83.85 -4.51

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

81.93

Max

87.81

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+57.8% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.7B

12B

Ankstesnė atidarymo kaina

88.36

Ankstesnė uždarymo kaina

83.85

Naujienos nuotaikos

By Acuity

50%

50%

153 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-12 23:12; UTC

Karštos akcijos

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

2026-03-12 22:15; UTC

Uždarbis

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

2026-03-12 21:42; UTC

Svarbiausios naujienos

Stryker Says Cyberattack Disruption Is Continuing

2026-03-12 21:29; UTC

Svarbiausios naujienos

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

2026-03-12 21:27; UTC

Uždarbis

Adobe CEO to Depart as AI Boosts Sales -- Update

2026-03-12 20:46; UTC

Uždarbis

Adobe Posts Higher Sales With CEO Set to Depart

2026-03-12 20:21; UTC

Svarbiausios naujienos

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

2026-03-12 23:57; UTC

Rinkos pokalbiai

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

2026-03-12 23:38; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-12 23:38; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

2026-03-12 22:13; UTC

Uždarbis

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

2026-03-12 22:13; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2026-03-12 22:13; UTC

Rinkos pokalbiai
Uždarbis

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

2026-03-12 21:16; UTC

Įsigijimai, susijungimai, perėmimai

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

2026-03-12 21:04; UTC

Uždarbis

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q Sales $865M >WPM

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q Net $558.3M >WPM

2026-03-12 21:02; UTC

Uždarbis

Wheaton Precious Metals 4Q EPS $1.23 >WPM

2026-03-12 20:57; UTC

Rinkos pokalbiai
Svarbiausios naujienos

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

2026-03-12 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-12 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-03-12 20:15; UTC

Įsigijimai, susijungimai, perėmimai

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

2026-03-12 20:10; UTC

Uždarbis

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

2026-03-12 20:05; UTC

Uždarbis

Adobe 1Q Rev $6.4B >ADBE

2026-03-12 20:05; UTC

Uždarbis

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

57.8% į viršų

12 mėnesių prognozė

Vidutinis 132.58 USD  57.8%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 21 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

21 ratings

20

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

153 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat